ECOG-ACRIN EA2161

Primary Category:

Treatment Protocols

Disease Category:

Carcinoid, Gastrointestinal, Neuroendocrine, Pancreatic

Status:

Closed

A Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors (PNET)

Effective December 27th, 2019, study EA2161 is permanently closed to accrual.

NCT#02893930